Vanguard Investments Australia’s Day One Biopharmaceuticals DAWN Stock Holding History

Vanguard Investments Australia’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,569	Closed	-$398K	–	2390
2026 Q1	$398K	Buy	+18,569	New	+$262K	﹤0.01%	1691

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Investments Australia's DAWN Position: Q2 2026 in Review

Vanguard Investments Australia sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 18,569 shares — an estimated $398K sold.

Vanguard Investments Australia first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $398K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Vanguard Investments Australia reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Vanguard Investments Australia sold 18,569 Day One Biopharmaceuticals shares in Q2 2026, an estimated $398K.
Vanguard Investments Australia first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Vanguard Investments Australia's Day One Biopharmaceuticals position peaked at $398K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.